Turkey is expected to be Europe's next–door emerging market: With its unique position between orient and occident and its focus on progress the country is set for growth. Projects in Turkey's emerging pharmaceutical industry offer great chances but also distinctive challenges – Chemgineering provided qualification and validation support for a Turkish pharmaceutical company in building a new plant for contract manufacturing. Read what two participants from Business and Technology Design experienced there.

Ten years after starting Saltigo is one of the world’s leading exclusive synthesis specialists. Its business development is based on know-how and experience, proprietary synthesis processes and a wide range of technologies and products. Now the company is to be invested around EUR 60 million in expanding the Leverkusen site by the end of 2017.

After the traditional blockbuster era the new blockbusters are specialty medicines — This may change the manufacturing strategy for many pharmaceutical companies and it means new opportunities and challenges for pharmaceutical manufacturing. But today’s technology and equipment require rethinking of the industry to meet the demands of the “new pharma reality”. Who is going to make the pace?

Process digitalization: The Solvay/Butachimie chemical platform in Chalampé is an illustrative example for the factory of the future — Using the simulation tool Simit from Siemens the company realizes the changeover from the previously used process control system to the PCS 7 system, which is a Siemens tool too.

Danish catalyst specialist Haldor Topsoe announced that it was going to acquire full ownership of German Ferrostaal Topsoe Projects GmbH. The acquisition adds project planning and development know-how to the company's portfolio of high-performance catalyst and proprietory technologies for the chemical and refining industries.

Novo Nordisk has broken ground on its new 2 billion US dollar production facility in Clayton, North Carolina.The facility will produce active pharmaceutical ingredients (API) for a range of Novo Nordisk's current and future GLP-1 and insulin products.

Pöyry has been awarded the EPCM contract as the firm was already involved in the study phase of the project. The development plan is scheduled to be complete by 2020.

The fewer the components the better — the insides of the pump type series MegaCPK is really as simple as that. This intelligent piece of re-engineering caters not only to lower maintenance costs, but also to higher operating reliability and optimised efficiency.

A treatment module developed at Fraunhofer IKTS provides a remedy against pharmaceutical residues in waste water and completely eliminates these harmful substances. Apart from water treatment, possible applications of this new technology also include chemical synthesis.

Frost & Sullivan’s recent intelligence, Global Analysis of Battery Materials Market, Forecast to 2023, examines the battery materials used in lead-acid and Li-ion batteries. The study finds that China, Japan and South Korea in Asia-Pacific (Apac) are proving to be lucrative markets for Lithium (Li)-ion battery material suppliers.